Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Inventory (2023 - 2024)

Mangoceuticals (MGRX) has disclosed Inventory for 2 consecutive years, with -$18501.0 as the latest value for Q4 2024.

  • Quarterly Inventory fell 200.0% to -$18501.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$18501.0 through Dec 2024, down 200.0% year-over-year, with the annual reading at -$18501.0 for FY2024, 200.0% down from the prior year.
  • Inventory hit -$18501.0 in Q4 2024 for Mangoceuticals, down from $13213.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $23494.0 in Q2 2023 to a low of -$18501.0 in Q4 2024.